Surgery Partners Provides Update on 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Surgery Partners (SGRY) PT Lowered to $13 at Jefferies Following 3Q
November 1, 2017 8:21 AM EDTJefferies lowered its price target on Surgery Partners (NASDAQ: SGRY) to $13.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report. Unlike many HC services peers, SGRY managed in Q3 to beat on top-line ($330MM vs $302MM consensus) and deliver inline EBITDA... More
